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Introduction: Herpes simplex virus is the most common cause of sporadic viral encephalitis. Cognitive impairments
persist in most patients who survive herpes simplex virus-caused encephalitis after undergoing currently available
treatments. This is the first report on the development of human cord blood-derived mononuclear cell
transplantation as a new treatment intervention to improve the prognosis of sequelae of viral encephalitis.
Case presentation: An 11-year-old Han Chinese boy developed sequelae of viral encephalitis with cognitive,
mental and motor impairments in the 8 months following routine treatments. Since receiving allogeneic cord
blood-derived mononuclear cell transplantation combined with comprehensive rehabilitation therapies 7 years ago,
the patient’s health has significantly improved and remained stable.
Conclusions: Human cord blood-derived mononuclear cell transplantation may be a potential therapeutic strategy
for treating the neuropsychiatric and neurobehavioral sequelae of viral encephalitis.Introduction
Viral encephalitis is a diffuse or focal inflammatory
process of the brain parenchyma caused by the infection
of a variety of viruses. It commonly presents with fever,
headache, seizures, disturbance of consciousness, and
dysfunction of movement, intelligence, and language in-
duced by focal central nervous system damage in the
acute stage [1]. Worldwide data indicate an annual inci-
dence of acute encephalitis ranging from 3.5 to 7.4 out
of 100,000, rising to 16 out of 100,000 in children [2].
There are numerous potential causes of viral encephal-
itis and the causes of 30% to 50% of cases may not be
identified even after extensive investigation [3]. There-
fore, the diagnosis of viral encephalitis can be defined if
the patient has the appropriate clinical presentation and
surrogate markers of brain inflammation, such as in-
flammatory cells in the cerebrospinal fluid (CSF) or
changes to brain imaging suggestive of inflammation
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reproduction in any medium, provided the orcause of sporadic viral encephalitis [2]. Most patients with
HSV-caused encephalitis (HSE) present with mental and
cognitive impairment and a long duration of the afore-
mentioned symptoms [5]. Current treatment methods for
viral encephalitis include the use of an antiviral drug with
good CSF penetration when the infection is caused by a
treatable virus, immunomodulatory treatment when indi-
cated, and prevention and control of the complications of
the disease [1,4]. However, it has been reported that cogni-
tive and other neuropsychiatric features persist in as many
as 80% or more of patients who have survived HSE [5].
One patient diagnosed with the sequelae of viral
encephalitis was admitted into the Nanshan Affiliated
Hospital of Guangdong Medical College (Shenzhen, China)
to seek stem cell transplantation due to cognitive, lan-
guage and mental impairments in the 8 months following
routine treatments for viral encephalitis. After receiving
allogeneic cord blood-derived mononuclear cell (CBMC)
transplantation combined with comprehensive rehabilita-
tion therapies, the patient obtained significant improve-
ments and maintained a stable condition for the following
5 years.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Eight years ago, an 11-year-old Han Chinese boy was
admitted to a local hospital with acute onset of "high
fever and coma". A physical examination showed high
body temperature, unconsciousness and recurrent sei-
zures. The diagnosis of “viral encephalitis complicated
with secondary epilepsy” was defined according to the
symptoms and examination results of CSF, electroenceph-
alography (EEG) and brain magnetic resonance imaging
(MRI). The patient received approximately 2 months of
anti-virus, seizure control, and supportive and symptom-
atic treatments while in the hospital. He was unable to
speak, lacked normal voluntary control of excretory func-
tions, and displayed emotional irritability upon discharge.
An EEG test before discharge revealed diffuse 2~3Hz δ
activity with middle to high amplitude waves within the
brain (no remarkable change to the previous test result).
The patient’s condition was not substantially changed by
other treatment interventions after discharge, including
rehabilitation therapies.
Seven years ago, the patient was admitted to the
Nanshan Affiliated Hospital of Guangdong Medical
College for stem cell treatment due to “sequelae of viral
encephalitis complicated with secondary epilepsy and
cognitive impairment”. A physical examination showed:
(1) Consciousness, but with severe cognitive impairment
on memory, thinking, understanding, and calculation;
(2) Mental disorders, presenting with panic, irritability,
shouting and crying; (3) Transcortical aphasia with
alexia, and agraphia; (4) Muscular tone of his four limbs
was grade 1- (Ashworth scale) with apraxia and the
patient was incapable of walking up or down stairs; (5)
Evaluation of “Activities of Daily Living” (ADL) revealing
complete dependence of feeding, urination and defecation
with a score of “0” on the Barthel Index (BI); (6) “0” score
on “Functional Independence Measure” (FIM); (7) No co-
operation for “Mini-Mental State Examination” (MMSE);
(8) “0” score on “Wechsler Intelligence Scale for Children”
(WISC) (Table 1). The blood test results were within nor-
mal range and the brain MRI showed white matter lesions
on the bilateral hemispheres. The patient was not taking
any medication on admission.
The patient received 6 allogeneic CBMC transplanta-
tions in combination with rehabilitation therapies. The
treatment protocol and patient consent were approvedTable 1 Evaluation of treatment efficacy: four scales pre-
and post-treatment
Scale ADL-BI FIM MMSE WISC
Pre-treatment 0 0 No cooperation 0
Post-treatment 100 123 29 73
Abbreviations: ADL Activities of Daily Living, BI Barthel Index, FIM Functional
Independence Measure, MMSE Mini-Mental State Examination, WISC Wechsler
Intelligence Scale for Children.by the local Institutional Review Board of the Nanshan
Affiliated Hospital of Guangdong Medical College under
the auspices of the National Ministry of Health. The
treatment procedure was clearly explained to the pa-
tient’s family and informed consent was obtained before
the initiation of each cell transplantation. The CBMCs
were provided by Shenzhen Beike Biotechnology Co.
Ltd. after human umbilical cord blood collection and
mononuclear cell extraction, cultivation and harvesting
[6]. To ensure the quality of CBMCs, a number of param-
eters were tested and confirmed before use, including
hepatitis B virus, hepatitis C virus, human immunodefi-
ciency virus, alanine aminotransferase, syphilis and endo-
toxin level. Approximately 1~3×107 CBMCs (containing
1.0% to 2.0% CD34+ cells, cell viability ≥95%) were trans-
fused per injection at 1-week intervals. The patient re-
ceived four cell infusions through intrathecal injection and
two cell infusions by intravenous injection. Rehabilitation
therapies, including scalp acupuncture [7] and speech and
cognitive training with the CE-1275 vocaSTIM®-Master
instrument (Physiomed GMDH, Germany), were applied
over three treatment courses with the duration of each
course lasting 20 days (once per day). No medication was
commenced during the treatment and on discharge from
the hospital.
The patient displayed remarkable improvements after
the 6 stem cell transplantations and 3 months of com-
prehensive rehabilitation therapies. He was slightly mal-
nourished when admitted and his appetite and eating
habits improved after stem cell treatment. Additional im-
provements were as follows: (1) Cognition – completely
normal function of calculation, long-term memory, orien-
tation and thinking, except for slightly inadequate short-
term memory; (2) Language – completely recovered
speaking, reading, writing and listening ability; (3) Move-
ment – completely recovered motor function; (4) Normal
mental condition without irritability or panic; (5) ADL –
completely independent daily life with “100” BI score; (6)
FIM score of 123, largely independent; (7) MMSE score of
29, effectively normal; (8) WISC score of 73, normal
intelligence (Table 1); (9) Video-EEG (June 2006) test re-
vealed significant improvements compared with previous
test results. A brain MRI scan was not performed post-
treatment.
The patient’s condition has not only remained stable
since discharge but also gradually improved to the point
that he was able to return to school to continue his
studies. He was able to catch up with the teaching mate-
rials and his exam scores for major subjects were a B+.
He successfully enrolled in high school 5 years later.
Twelve tumor indicators, including carbohydrate antigen
(CA) 19–9, CA242, CA-125, CA 15-3, neuron-specific
enolase, carcinoembryonic antigen, alpha-fetoprotein,
total prostate-specific antigen (PSA), free PSA, ferritin,
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were within the normal range when tested at 2 years
post-treatment (Table 2). In the 5-year follow-up, the pa-
tient showed a height of 175cm, normal physiological in-
dexes, cognitive and language capacity, and normal test
results of tumor indicators (Table 2). These therapeutic
effects have been fully affirmed by clinicians from other
non-related hospitals when performing their own inde-
pendent checks on the patient.
Discussion
This patient was diagnosed with viral encephalitis. The
results of both the EEG and brain MRI indicated diffuse
lesions in the whole brain and the natural cure of these
lesions was unsubstantial. The patient presented with
severe disturbances of advanced brain functions on lan-
guage, cognition, and thinking in the 8 months following
routine treatments, leading to a life of complete depen-
dency. After receiving 6 allogeneic CBMC transplantations
combined with comprehensive rehabilitation therapies,
the patient regained normal function of his language,
thinking, understanding, long-term memory, and cogni-
tion. In the 5 years of follow ups since the stem cell treat-
ment, the patient’s physiological indicators were shown to
be in the normal ranges and his capacity for thinking, lan-
guage, and mental awareness was restored and maintained
at a level similar to that of before the onset of the disease.
These preliminary clinical data suggest that stem cell
transplantation may be a new treatment option for the
severe sequelae of viral encephalitis.
We have previously reported on the safety and freedom
from immunologically mediated adverse effects of alloge-








CA 19-9 (u/mL) <35.0 2.57 2.68
CA 242 (ng/mL) <20.0 1.70 2.40
CA125 (u/mL) <35.0 8.82 7.05
CA15-3 (u/mL) <35.0 6.42 9.48
NSE (ng/mL) <13.0 1.70 2.40
CEA (ng/mL) <5.0 3.33 4.90
AFP (ng/mL) <20.0 2.16 1.71
PSA (ng/mL) <5.0 0.41 0.22
free PSA (ng/mL) <1.0 0.16 0.09
Ferritin (ng/mL) <322.0 77.59 69.67
β-hCG (ng/mL) <3.0 0.24 0.29
GH (ng/mL) <7.50 0.17 0.10
Abbreviations: AFP alpha-fetoprotein, β-hCG β-human chorionic gonadotropin,
CA carbohydrate antigen, CEA carcinoembryonic antigen, GH growth hormone,
NSE neuron-specific enolase, PSA total prostate-specific antigen.and myeloablation [6]. This patient’s blood test results of
tumor indicators and his physical condition demonstrated
no evidence of tumor formation during the 5 years of fol-
low ups. This case further demonstrates the long-term
safety of using non-matched, allogeneic cord blood cells to
treat non-hematopoietic conditions. It also indicates that
CBMC transplantation may be a safe and effective therapy
intervention for the sequelae of viral encephalitis.
Abundant animal research has demonstrated that
administered cord blood stem cells can enter the brain,
survive, and migrate to damaged areas to improve func-
tional recovery for various neurological diseases [8-10].
A previous case series study of 30 patients with heredi-
tary ataxia indicated that treatment using both intraven-
ous and intrathecal infusion of CBMCs combined with
rehabilitation therapy improved ataxia along with func-
tionality and quality of life [11]. Mechanism studies
suggest multi-potent cells in the heterogeneous CBMC
population may not only differentiate into neurons and
astrocytes to act as a cell replacement source, but also
produce antioxidants, several neurotrophic and angio-
genic factors and modulate immune and inflammatory
reaction [12,13]. CBMC graft-mediated brain repair in-
volves neurotrophic effects resulting from the release of
various growth factors that afford cell survival, angioge-
nesis, and anti-inflammation to rescue the injured nerves
and support the regeneration of neurons and glial cells
[14]. These multiple restorative and protective effects
from CBMC transplantation may be interdependent and
act in harmony to exert therapeutic benefits in this case.
However, the exact mechanisms of action need to be
further explored in the future with basic and clinical
studies.
Modern rehabilitation theory believes rehabilitation
therapy can aid regeneration of damaged neurons and
functional plasticity of the central nervous system after
brain injury [15-17]. Furthermore, rehabilitation therapy
may exert a synergistic action on grafted cells to pro-
mote functional recovery [11,18,19]. Recent studies have
demonstrated that rehabilitation therapy can activate the
survival and differentiation of grafted cells, initiate syn-
thesis and secretion of endogenous neurotrophic factors
in the ambient tissues at the lesion sites, and down-
regulate expression of glial fibrillary acidic protein and
chondroitin sulfate proteoglycan protein to prevent axonal
degeneration and improve axonal regeneration [20,21].
Therefore, we adopted comprehensive rehabilitation ther-
apies to combine with the CBMC transplantation to assist
in the promotion of the patient’s functional recovery.
Conclusions
Viral encephalitis is still considered a major medical
problem. Severe neurological sequelae are common even
though correct diagnosis and adequate antiviral therapy
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vention able to completely cure the cognitive dysfunc-
tion patients suffer due to viral encephalitis. The
development of new treatment intervention to improve
the prognosis of the sequelae of viral encephalitis is
needed. This case report has indicated that CBMC trans-
plantation combined with rehabilitation therapy might
be a potential therapeutic strategy for the neuropsychi-
atric and neurobehavioral sequelae of viral encephalitis.
Future clinical studies with more samples are needed to
further validate safety and treatment efficacy.
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